SenzaGen AB (STO:SENZA)
5.34
0.00 (0.00%)
Jul 20, 2026, 4:47 PM CET
SenzaGen AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 38.06 | 26.78 | 39.61 | 17.62 | 39.98 | 69.16 |
Cash & Short-Term Investments | 38.06 | 26.78 | 39.61 | 17.62 | 39.98 | 69.16 |
Cash Growth | 9.71% | -32.38% | 124.74% | -55.91% | -42.20% | -22.59% |
Accounts Receivable | 10.32 | 13.89 | 13.69 | 10.59 | 9.09 | 6.27 |
Other Receivables | 9.8 | 7.21 | 4.83 | 4.1 | 3.31 | 1.57 |
Total Trade Receivables | 20.12 | 21.1 | 18.51 | 14.69 | 12.4 | 7.84 |
Inventory | - | - | - | 6.23 | 3.61 | 3.2 |
Other Current Assets | 3.49 | 2.67 | 0.95 | 1.82 | 1.64 | 1.2 |
Total Current Assets | 64.84 | 52.43 | 62.81 | 40.36 | 57.63 | 81.41 |
Net Property, Plant & Equipment | 15.89 | 17.16 | 7.95 | 1.81 | 2.58 | 3.23 |
Other Intangible Assets | 30.12 | 29.88 | 32.05 | 34.02 | 38.11 | 36.06 |
Goodwill | 16.81 | 16.62 | 17.64 | 20.99 | 21.65 | 13.11 |
Other Long-Term Assets | 0.08 | 0.07 | 0.05 | - | - | - |
Total Assets | 127.74 | 116.15 | 120.5 | 97.18 | 119.95 | 133.81 |
Accounts Payable | 4.88 | 5.59 | 3.09 | 5.69 | 4.42 | 3.14 |
Accrued Expenses | 1.95 | 1.9 | 5.2 | 11.93 | 13.29 | 9.05 |
Current Portion of Leases | 3.77 | 3.7 | 2.26 | - | - | - |
Unearned Revenue | 0.41 | 2.04 | 0.95 | 0.37 | 0.1 | 1.55 |
Other Current Liabilities | 11 | 10.02 | 12.72 | 9.91 | 11.24 | 9.12 |
Total Current Liabilities | 22.01 | 23.25 | 24.21 | 27.9 | 29.05 | 22.85 |
Long-Term Debt | 5.16 | 5.39 | 1.78 | 1.67 | 1.21 | 0.71 |
Long-Term Leases | 8.86 | 9.78 | 3.63 | - | - | - |
Other Long-Term Liabilities | 14.02 | 15.17 | 5.42 | 1.67 | 1.21 | 0.71 |
Total Long-Term Liabilities | 28.04 | 30.34 | 10.83 | 3.35 | 2.41 | 1.43 |
Total Liabilities | 50.04 | 53.59 | 35.04 | 31.24 | 31.46 | 24.28 |
Common Stock | 1.63 | 1.48 | 1.48 | 1.21 | 1.21 | 1.2 |
Additional Paid-in Capital | 310.88 | 294.9 | 294.9 | 0.06 | 0.92 | 2.74 |
Accumulated Other Comprehensive Income | 0.11 | 0.01 | 0.71 | 3.72 | 3.59 | 0.69 |
Retained Earnings | -220.9 | -218.65 | -206.21 | 62.62 | 83.99 | 105.61 |
Shareholders' Equity | 91.72 | 77.73 | 90.87 | 67.61 | 89.7 | 110.24 |
Total Liabilities & Equity | 127.74 | 116.15 | 120.5 | 97.18 | 119.95 | 133.81 |
Total Debt | 17.78 | 18.87 | 7.68 | 1.67 | 1.21 | 0.71 |
Net Cash (Debt) | 20.28 | 7.91 | 31.93 | 15.95 | 38.77 | 68.45 |
Net Cash Growth | 156.28% | -75.22% | 100.18% | -58.86% | -43.36% | -23.39% |
Net Cash Per Share | 0.68 | 0.27 | 1.17 | 0.66 | 1.61 | 3.14 |
Book Value | 91.72 | 77.73 | 90.87 | 67.61 | 89.7 | 110.24 |
Book Value Per Share | 3.06 | 2.63 | 3.33 | 2.80 | 3.72 | 5.05 |
Tangible Book Value | 44.79 | 31.23 | 41.18 | 12.6 | 29.95 | 61.07 |
Tangible Book Value Per Share | 1.49 | 1.06 | 1.51 | 0.52 | 1.24 | 2.80 |